BFM
GCVRZ

Boothbay Fund Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Boothbay Fund Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-243,574
Closed -$210K – 1228
2019
Q4 		$210K Buy
+243,574
New +$187K 0.02% 698

Boothbay Fund Management's GCVRZ Position: Q1 2020 in Review

Boothbay Fund Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 243,574 shares — an estimated $210K sold.

Boothbay Fund Management first reported a position in GCVRZ in Q4 2019 and held it in 1 quarter. The position peaked at $210K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Boothbay Fund Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 243,574 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $210K.
  • Boothbay Fund Management first reported a position in Sanofi Contingent Value Rights in Q4 2019 and held it in 1 quarter.
  • Boothbay Fund Management's Sanofi Contingent Value Rights position peaked at $210K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Boothbay Fund Management's 13F filing for Q1 2020, filed 15 May 2020.